መነሻ › Multiple Myeloma › አሪዞና › Phoenix
በPhoenix፣ AZ ለMultiple Myeloma የሚደረጉ ክሊኒካዊ ጥናቶች
ለMultiple Myeloma የሚደረጉ 16 ጥናቶች በPhoenix እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Mayo Clinic 1, Phoenix
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Mayo Clinic Phoenix, Phoenix
A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Mayo Clinic Phoenix, Mayo Clinic Building, Phoenix
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
ተሳታዮችን በመፈለግ ላይደረጃ 4
- Mayo Clinic Cancer Center-Scottsdale, Phoenix
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Cancer Treatment Centers of America-Phoenix, Phoenix
Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Mayo Clinic Hospital in Arizona, Phoenix
Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Mayo Clinic Arizona, Phoenix
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Cancer Center at Saint Joseph's, Phoenix
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Research Site, Phoenix
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Research Site, Phoenix
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Mayo Clinic - Arizona, Phoenix
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Mayo Clinic in Arizona - Phoenix, Phoenix
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Mayo Clinic Arizona /ID# 251405, Phoenix
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Cancer Center at Saint Joseph's, Phoenix
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Banner University Medical Center Tucson, University of Arizona, Phoenix
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- GSK Investigational Site, Phoenix
በሌሎች ከተሞች ለMultiple Myeloma የሚደረጉ ጥናቶች
- New York City, NY60 ጥናቶች
- Boston, MA42 ጥናቶች
- Atlanta, GA41 ጥናቶች
- Houston, TX38 ጥናቶች
- Durham, NC37 ጥናቶች
- Nashville, TN32 ጥናቶች
- Denver, CO27 ጥናቶች
- Rochester, MN24 ጥናቶች
- St. Louis, MO24 ጥናቶች
- Columbus, OH24 ጥናቶች
- Baldwin Park, CA23 ጥናቶች
- Chicago, IL22 ጥናቶች
በPhoenix ውስጥ ያሉ ሌሎች ጥናቶች
- የጡንቻ ካንሰር25 ጥናቶች
- የኮሎሬክታል ካንሰር25 ጥናቶች
- ከባድ ሰውነት22 ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር20 ጥናቶች
- Metastatic Cancer20 ጥናቶች
- የልብ ድካም18 ጥናቶች
- የፕሮስቴት ካንሰር17 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)17 ጥናቶች
- የፓንክሪያስ ካንሰር16 ጥናቶች
- የልብና የደም ዝውውር ሕመም16 ጥናቶች
- አልዛይመር በሽታ15 ጥናቶች
- ከመጠን በላይ ክብደት15 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።